Literature DB >> 19334373

CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity.

F Mastrandrea1, F P Semeraro, G Coradduzza, M Manelli, G Scarcia, F Pezzuto, G Serio.   

Abstract

Celiac disease (CD) is a chronic inflammatory enteropathy of the small bowel resulting from a local TH1-mediated reaction to wheat gliadins and barley, rye and oat prolamins with the development of auto-antibodies to transglutaminases. As well as for other chronic inflammatory diseases, genetic background and environmental factors participate to pathogenesis. An increased traffic of CD34+ hemopoietic precursor and stem cells (HPC) has been reported in peripheral blood (PB) of subjects with allergic diseases that share in their pathogenesis immuno-mediated reactions, genetic and environmental factors. The aim of the present work was to investigate the CD34+ cell traffic and H2/H1 polarization of lymphoid T-cell lineage, in the peripheral blood of subjects with CD, by means of flow-cytometric techniques. Group A of control was of 20 healthy subjects, aged 5 to 58 years. Study population (Group B) was of twenty-eight patients, all females aged 13 to 70, receiving firstly a CD diagnosis at the SS Annunziata Hospital Digestive Physiopathology Out-standings' by means of clinical, serologic and small intestinal biopsy findings. Peripheral CD34+ HPCs were significantly increased in Group B (median value 0.16) when compared with Group A (median value 0.03) (p 0.0001) but did not correlate either with anti-transglutaminase (tTG) antibody levels (IgA: p 0.226; IgG: p 0.810) or with histological damage severity (p 0.41) that, on the contrary, was significantly related with anti-tTG IgA antibodies (p 0.027). Celiac circulating CD3+CD4+ lymphocytes expressed a chemokine-receptor pattern Th2-skewed in all but three patients investigated. Concluding, the CD34+ HPC highly increased peripheral traffic observed in celiac disease appears more related to a basic and emerging as common defect shared by chronic inflammatory diseases than to the gliadin-specific Th1 local reactions. Data are consistent with a potential NFkappaB deficiency and consequent prevalence of apoptotic versus survival programs leading to excessive cell-death; to replace lost cells a supplementary bone-marrow derived precursors supply, further to that physiologically provided by the gut stem cell "niches" that are cryptopatches, could be required.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19334373

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  6 in total

Review 1.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

2.  Baicalin down regulates the expression of TLR4 and NFkB-p65 in colon tissue in mice with colitis induced by dextran sulfate sodium.

Authors:  Jinshan Feng; Cancan Guo; Yuzhen Zhu; Liping Pang; Zheng Yang; Ying Zou; Xuebao Zheng
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 3.  Intestinal stem cells and celiac disease.

Authors:  Anna Chiara Piscaglia
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

4.  Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice.

Authors:  Jinhong Meng; Carl F Adkin; Shi-wen Xu; Francesco Muntoni; Jennifer E Morgan
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

5.  Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease.

Authors:  Anna Chiara Piscaglia; Sergio Rutella; Lucrezia Laterza; Valentina Cesario; Mariachiara Campanale; Immacolata Alessia Cazzato; Gianluca Ianiro; Federico Barbaro; Luca Di Maurizio; Giuseppina Bonanno; Tonia Cenci; Giovanni Cammarota; Luigi Maria Larocca; Antonio Gasbarrini
Journal:  J Transl Med       Date:  2015-07-11       Impact factor: 5.531

Review 6.  Mesenchymal stem cells as potential therapeutic approaches in celiac disease.

Authors:  Ali Moheb-Alian; Flora Forouzesh; Mohammad Rostami-Nejad; Kamran Rostami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.